FL can also transform into a composite lymphoma, combining a HGBL with BCL2 and/or BCL6 and MYC rearrangements, and a B-ALL characterized by a loss of maturity markers, such as CD20 and surface immunoglobulins [2, 8–15]. This evidence concerns the gene BCL6 and lymphoma.